Not exact matches
Dorothy Romanus, lead author of the study, states «this
analysis supports the value of multiplexed testing for EGFR and ALK
gene rearrangements followed by molecularly - guided therapy in decisions surrounding coverage of related testing and targeted therapy.
This
analysis discovered an average of 97 structural
rearrangements of the genome per tumor, and some 9,653 mutations of various types in 5,712
genes.
The
analysis also found that a significant fraction of tumors contained
rearrangements and mutations of a
gene called PREX2, and experiments confirmed that cancer - associated mutations of PREX2 promoted the growth of human melanoma cells in mice.
Details on the recurrently mutated
genes, and structural and functional
analysis of somatic
rearrangements, are provided as supplementary materials.
MRD was assessed using polymerase chain reaction
analysis of Ig / TCR
gene rearrangements.